[go: up one dir, main page]

PH31009A - Peptides having bradykinin antagonist action. - Google Patents

Peptides having bradykinin antagonist action.

Info

Publication number
PH31009A
PH31009A PH40920A PH40920A PH31009A PH 31009 A PH31009 A PH 31009A PH 40920 A PH40920 A PH 40920A PH 40920 A PH40920 A PH 40920A PH 31009 A PH31009 A PH 31009A
Authority
PH
Philippines
Prior art keywords
amino acid
peptides
bradykinin
direct bond
optionally
Prior art date
Application number
PH40920A
Inventor
Henke Stephan Anagnosto Jochen
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH31009A publication Critical patent/PH31009A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I> in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aromatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or optionally a direct bond, I is -OH, -NH2 or -NHC2H5 and K is a radical -NH(CH2)-1-4-CO- or is a direct bond, have bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are promoted, induced or sustained by bradykinin and bradykinin- related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
PH40920A 1988-11-24 1990-07-30 Peptides having bradykinin antagonist action. PH31009A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3839581 1988-11-24
DE3916291 1989-05-19
DE3918225 1989-06-03

Publications (1)

Publication Number Publication Date
PH31009A true PH31009A (en) 1997-12-23

Family

ID=27198531

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40920A PH31009A (en) 1988-11-24 1990-07-30 Peptides having bradykinin antagonist action.

Country Status (26)

Country Link
EP (1) EP0370453B1 (en)
JP (1) JPH07121956B2 (en)
KR (1) KR0139632B1 (en)
CN (1) CN1035006C (en)
AT (1) ATE107318T1 (en)
AU (1) AU612054B2 (en)
CA (1) CA1340667C (en)
CY (2) CY2028A (en)
CZ (1) CZ282384B6 (en)
DE (3) DE3938751A1 (en)
DK (1) DK175344B1 (en)
ES (1) ES2057071T3 (en)
FI (1) FI94353C (en)
HK (1) HK1006716A1 (en)
HU (2) HU210566B (en)
IE (1) IE63490B1 (en)
IL (1) IL91298A (en)
LU (1) LU91499I2 (en)
LV (1) LV10720B (en)
MX (1) MX9203277A (en)
NL (1) NL300359I2 (en)
NO (2) NO177597C (en)
NZ (1) NZ230244A (en)
PH (1) PH31009A (en)
PT (1) PT91692B (en)
SK (1) SK490689A3 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013270A1 (en) * 1990-04-26 1991-10-31 Hoechst Ag PEPTIDES WITH BRADYKININ ANTAGONISTIC EFFECT
US5648333A (en) * 1988-11-24 1997-07-15 Hoechst Aktiengesellschaft Peptides having bradykinin antagonist action
EP0502987B1 (en) * 1989-12-08 1994-08-31 Trustees Of Boston University Acylated bradykinin antagonists and uses therefor
MX9100717A (en) * 1990-08-24 1992-04-01 Syntex Inc BRADIQUININE ANTAGONISTS
US5416191A (en) * 1991-04-01 1995-05-16 Cortech, Inc. Bradykinin antagonists
US5843900A (en) * 1991-04-01 1998-12-01 Cortech, Inc. Bradykinin antagonists
CA2106762C (en) * 1991-04-19 2000-10-10 Donald J. Kyle Bradykinin antagonist peptides
ES2123556T3 (en) 1991-04-19 1999-01-16 Scios Nova Inc BRADIQUININE TYPE PEPTIDES.
US6770741B1 (en) 1991-04-19 2004-08-03 Scios Inc. Bradykinin antagonist peptides
HUT63060A (en) * 1991-08-22 1993-07-28 Hoechst Ag Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
TW199863B (en) * 1991-12-21 1993-02-11 Hoechst Ag
WO1993017701A1 (en) * 1992-03-12 1993-09-16 The Administrators Of The Tulane Educational Fund Endothelin receptor-binding peptides
TW258739B (en) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (en) * 1992-06-18 1994-08-19 Adir New peptide derivatives with bradykinin antagonist activity, their preparation process and the pharmaceutical compositions containing them.
US5610142A (en) * 1992-10-08 1997-03-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
US5541286A (en) * 1992-10-08 1996-07-30 Scios Nova Inc. Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5686565A (en) * 1992-10-08 1997-11-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
US5817756A (en) * 1993-09-09 1998-10-06 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (en) * 1993-12-31 1995-07-13 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment of viral diseases
DE69533704D1 (en) * 1994-03-09 2004-12-02 Cortech Inc BRADYKININ ANTAGONIST PEPTIDE WITH N-SUBSTITUTED GLYCINES
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US6407059B1 (en) 1994-06-08 2002-06-18 Peptor Limited Conformationally constrained backbone cyclized peptide analogs
WO1996039425A2 (en) * 1995-06-05 1996-12-12 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
FR2737408B1 (en) * 1995-07-31 1997-09-05 Oreal USE OF A BRADYKININE ANTAGONIST IN A COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITION AND COMPOSITION OBTAINED
US5834431A (en) * 1995-09-08 1998-11-10 Cortech, Inc. Des-Arg9 -BK antagonists
US5849863A (en) * 1995-09-08 1998-12-15 University Of Colorado Cytolytic bradykinin antagonists
FR2739553B1 (en) 1995-10-06 1998-01-02 Oreal USE OF BRADYKININE ANTAGONISTS TO STIMULATE OR INDUCE HAIR GROWTH AND / OR STOP THE HAIR LOSS
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
DE19612067A1 (en) * 1996-03-27 1997-10-02 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment of chronic fibrogenetic liver diseases and acute liver diseases
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
DE19642289A1 (en) 1996-10-14 1998-04-16 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment and prevention of Alzheimer's disease
DE10304994A1 (en) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh The use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
CN102532267B (en) * 2012-02-09 2014-06-18 深圳翰宇药业股份有限公司 Method for preparing icatibant
CN104043101B (en) * 2014-05-23 2016-04-20 杭州阿德莱诺泰制药技术有限公司 A kind of icatibant composition for injection and preparation method thereof and preparation
KR102099509B1 (en) 2018-07-27 2020-04-09 강경순 Supports for fruit trees
CN111944016B (en) * 2020-08-25 2022-04-29 台州吉诺生物科技有限公司 Preparation method of icatibant acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3044236A1 (en) * 1980-11-25 1982-06-16 Hoechst Ag, 6000 Frankfurt AMINO ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
FR2487829A2 (en) * 1979-12-07 1982-02-05 Science Union & Cie NOVEL SUBSTITUTED IMINO ACIDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
DE3227055A1 (en) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt NEW DERIVATIVES OF 2-AZA-BICYCLO (2.2.2) OCTAN-3-CARBONIC ACID, METHOD FOR THE PRODUCTION THEREOF, THEIR SUBSTANCES AND THE USE THEREOF, AND 2-AZA-BICYCLO (2.2.2) OCTAN-3-CARBONIC ACID AS ANSWER FOR THEIR PRODUCTION
FR2575753B1 (en) * 1985-01-07 1987-02-20 Adir NOVEL PEPTIDE DERIVATIVES WITH NITROGEN POLYCYCLIC STRUCTURE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides

Also Published As

Publication number Publication date
CZ282384B6 (en) 1997-07-16
PT91692A (en) 1990-03-30
ES2057071T3 (en) 1994-10-16
NL300359I2 (en) 2009-02-02
IE63490B1 (en) 1995-05-03
CY2028A (en) 1998-02-20
DK384089A (en) 1990-05-25
NO177597B (en) 1995-07-10
CY2008022I1 (en) 2009-11-04
KR0139632B1 (en) 1998-07-01
NO893193L (en) 1990-05-25
SK279315B6 (en) 1998-09-09
SK490689A3 (en) 1998-09-09
EP0370453A3 (en) 1991-12-04
HU210712A9 (en) 1995-06-28
NO2008016I2 (en) 2012-10-01
DE58907889D1 (en) 1994-07-21
LV10720B (en) 1996-02-20
IL91298A0 (en) 1990-03-19
IE892522L (en) 1990-05-24
CA1340667C (en) 1999-07-20
DK384089D0 (en) 1989-08-04
FI893738A0 (en) 1989-08-08
HU210566B (en) 1995-05-29
FI893738A (en) 1990-05-25
EP0370453A2 (en) 1990-05-30
CY2008022I2 (en) 2009-11-04
AU612054B2 (en) 1991-06-27
PT91692B (en) 1995-05-31
NL300359I1 (en) 2008-11-03
JPH07121956B2 (en) 1995-12-25
ATE107318T1 (en) 1994-07-15
EP0370453B1 (en) 1994-06-15
DE3938751A1 (en) 1990-05-31
LV10720A (en) 1995-06-20
HK1006716A1 (en) 1999-03-12
NO893193D0 (en) 1989-08-08
MX9203277A (en) 1992-07-01
IL91298A (en) 1994-05-30
NZ230244A (en) 1992-06-25
DK175344B1 (en) 2004-08-30
CN1042918A (en) 1990-06-13
CZ490689A3 (en) 1997-03-12
AU3943189A (en) 1990-05-31
NO2008016I1 (en) 2008-11-17
DE122008000066I2 (en) 2009-11-05
KR900007870A (en) 1990-06-02
FI94353C (en) 1995-08-25
CN1035006C (en) 1997-05-28
HUT52527A (en) 1990-07-28
DE122008000066I1 (en) 2009-05-20
LU91499I2 (en) 2009-01-19
JPH02184697A (en) 1990-07-19
FI94353B (en) 1995-05-15
NO177597C (en) 1995-10-18

Similar Documents

Publication Publication Date Title
PH31009A (en) Peptides having bradykinin antagonist action.
AU6092490A (en) Peptides having bradykinin antagonist action
HK1006843A1 (en) Peptide antagonists of bradykinin